Module XVI-B: Clinical Revolution in Cardiovascular Health and Disease: Dyslipidemia, Coronary Heart Disease and Congestive Heart Failure

The pathophysiology, clinical review and application of advanced lipid testing and treatment of dyslipidemia with nutrition, nutritional supplements, exercise, lifestyle changes and drugs will be discussed and integrated into your clinical practice. There will be an in-depth review and discussion of CHD risk factors, pathophysiology, clinical presentation, laboratory testing and noninvasive CV diagnostic tests and integrative treatments for CHD, CVD and CHF. Additional time is devoted to clinical case presentations and clinical application of all didactic lectures with interaction and Q & A with the professors.

View Objectives
Physician Allied Health

Module XVI-B: Clinical Revolution in Cardiovascular Health and Disease

January 26-28, 2017 in Boca Raton, FL
Add to Cart Add to Cart
View Continuing Education Information

Schedule

Thursday January 26, 2017:

7:30 am

Integrative Management of Dyslipidemia and Dyslipidemia - Induced Cardiovascular Disease with Nutrition, Nutritional Supplements, Exercise, Weight Management and Other Lifestyle Modifications: Pathophysiology

Mark Houston, MD, MS, MSc

2 hr

9:30 am

Break

 

 

10:00 am

Integrative Management of Dyslipidemia and Dyslipidemia - Induced Cardiovascular Disease with Nutrition, Nutraceutical Supplements, Exercise, Weight Management and Other Lifestyle Modifications: Clinical Evaluation, Labs and Advanced Lipid Testing

Mark Houston, MD, MS, MSc

2 hr

12:00 pm

Lunch (on your own)

 

 

1:30 pm

Integrative Management of Dyslipidemia and Dyslipidemia - Induced Cardiovascular Disease with Nutrition, Nutraceutical Supplements, Exercise, Weight Management and Other Lifestyle Modifications: Treatment - Part 1

Mark Houston, MD, MS, MSc

2 hr

3:30 pm

Break

 

 

4:00 pm

Integrative Management of Dyslipidemia with Nutrition, Nutraceutical Supplements, Exercise, Weight Management, Other Lifestyle Modifications: Treatment - Part 2

Mark Houston, MD, MS, MSc

2 hr

6:00 pm

Close of session

 

 

Friday January 27, 2017:

7:30 am

Cardiovascular and Coronary Heart Disease Risk Factors and Mediators: Expanded Testing, Interpretation and Treatment

Mark Houston, MD, MS, MSc

2 hr

9:30 am

Break

 

 

10:00 am

Cardiovascular and Coronary Heart Disease Risk Factors and Mediators: Expanded Testing, Interpretation and Treatment and CHD Evaluation, Testing and Treatment

Mark Houston, MD, MS, MSc

2 hr

12:00 pm

Lunch (on your own)

 

 

1:30 pm

Metabolic and Integrative Cardiology: Pathophysiology, Clinical Evaluation and Treatment: Congestive Heart Failure (Systolic and Diastolic), Coronary Heart Disease and Myocardial Infarction

Mark Houston, MD, MS, MSc

2 hr

3:30 pm

Break

 

 

4:00 pm

Non-Invasive Cardiovascular Testing with Endothelial Function, MCG, CPET, TMT, CAPWA, ABI, Carotid US, ECHO Laboratory Evaluation, and Protocols

Mark Houston, MD, MS, MSc

1 hr

5:00 pm

Close of session

 

 

Saturday January 28, 2017:

7:00 am

Coronary Heart Disease and MI: Protocols, Summary and Cases

Mark Houston, MD, MS, MSc

2 hr

9:00 am

Break

 

 

9:30 am

Pharmacologic Therapy for Dyslipidemia

Sergio Fazio, MD

2 hr

11:30 pm

Lunch (on your own)

 

 

1:00 pm

Cardiac Arrhythmias: Diagnosis, Evaluation and Treatment Using an Integrative and Metabolic Medicine Model

Joel Kahn MD

2 hr

3:00 pm

Break

 

 

3:30 pm

Cardiovascular Testing: Non Invasive and Invasive: Nuclear Medicine Studies, Stress ECHO, IVUS, MRI/MRA, SPECT, PET, Angiograms

Joel Kahn MD

1 hr

4:30 pm

Close of session

 

 

Sergio Fazio, MD, PhD

Sergio Fazio, MD, PhD

Dr. Fazio received his MD from the University of Rome, where he completed internal medicine training and a fellowship in metabolic diseases. He obtained a PhD in Experimental Medicine from the University of Siena. In 1988, Dr. Fazio joined the University of California, San Francisco as Instructor in Medicine. In 1993, he joined Vanderbilt University first as Assistant Professor, then Associate Professor (1998) and Professor (2002). In 2011 he was given the Cornelius Vanderbilt Chair to become chief of CVD Prevention. Since 2014 he holds the William and Sonja Connor chair of Preventive Cardiology at OHSU, and is the Director of the Center for Preventive Cardiology. Dr. Fazio studies lipids and atherosclerosis. He has been PI on over 20 NIH grants, has published over 220 papers, and is currently secretary of the American Board of Clinical Lipidology, and editorial board member for ATVB, JLR, Circ Res, and J Clin Lipidol.

Joel Kahn, MD

Joel Kahn, MD

Joel Kahn, MD, is a plant based cardiologist whose personal mission is to prevent 1 million heart attacks over the next two years. He is known as “America’s Holistic Heart Doc” and graduated Summa cum Laude from the University of Michigan, Ann Arbor. Dr. Kahn has been practicing invasive, interventional and preventive cardiology in Detroit since 1990. He is a Clinical Professor of Medicine (Cardiology) at Wayne State University School of Medicine and Associate Professor of Medicine at Oakland University Beaumont School of Medicine. In 2013, Dr. Kahn received a certification from the University of South Florida in Metabolic Cardiology, and became the first physician to complete the program in the world. The American Academy of Anti-Aging Medicine has also certified Dr. Kahn in Metabolic Cardiology.

Reader’s Digest magazine selected Dr. Kahn for their Holistic Heart Doc column and their publishing arm published his book, The Whole Heart Solution, an Amazon #1 Top Selling book. His second book, Dead Execs Don’t Get Bonuses, was published in 2015 and is on the #1 Bestseller List as well. Dr. Kahn also appears regularly on Fox TV 2 in Detroit as a health commentator and a Member of the Yahoo Health Advisory Board.

MARK C. HOUSTON, MD, MS, MSc, ABAARM, FACP, FAHA, FASH, FACN, FMNM

MARK C. HOUSTON, MD, MS, MSc, ABAARM, FACP, FAHA, FASH, FACN, FMNM

Dr. Mark Houston is Associate Clinical Professor of Medicine at Vanderbilt University School of Medicine, Clinical Instructor in the Department of Physical Therapy and Health Care Sciences at George Washington University (GWU), Director of the Hypertension Institute and Vascular Biology and Medical Director of the Division of Human Nutrition at Saint Thomas Hospital in Nashville, TN .

Dr. Houston was selected as one of the Top Physicians in Hypertension in the US in 2008-2014 by the Consumer Research Council, and by USA Today as one of the Most Influential Doctors in the US in both Hypertension and Hyperlipidemia twice in 2009- 2010. He was selected as The Patient’s Choice Award in 2010 -2012 by Consumer Reports USA.

He is triple boarded certified by the American Board of Internal Medicine (ABIM), the American Society of Hypertension (ASH) (FASH) and the American Board of Anti-Aging and Regenerative Medicine (ABAARM, FMNM). He holds two Masters of Science degrees in HUMAN NUTRITION from the University of Bridgeport, CT and another in METABOLIC and NUTRITIONAL MEDICINE (University of South Florida School of Medicine-Tampa).

Dr. Houston has presented over 10,000 lectures, nationally and internationally and published over 250 medical articles, scientific abstracts in peer reviewed medical journals, books and book chapters. He is an author, teacher, clinician and researcher.

When is this module offered?

Educationally Partnered With

A4M LogoWashington Logo
White Bottom Arrow